Section 388-865-0570. Rights related to antipsychotic medication.  


Latest version.
  • All consumers have a right to make an informed decision regarding the use of antipsychotic medication consistent with the provisions of RCW 71.05.370(7) and 71.05.215. The provider must develop and maintain a written protocol for the involuntary administration of antipsychotic medications, including the following requirements:
    (1) The clinical record must document:
    (a) The physician's attempt to obtain informed consent;
    (b) The consumer was asked if he or she wishes to decline treatment during the twenty-four hour period prior to any court proceeding wherein the consumer has the right to attend and is related to his or her continued treatment. The answer must be in writing and signed when possible. In the case of a child under the age of eighteen, the physician must be able to explain to the court the probably effects of the medication.
    (c) The reasons why any anti-psychotic medication is administered over the consumer's objection or lack of consent.
    (2) The physician may administer anti-psychotic medications over a consumer's objections or lack of consent only when:
    (a) An emergency exists, provided there is a review of this decision by a second physician within twenty-four hours. An emergency exists if:
    (i) The consumer presents an imminent likelihood of serious harm to self or others;
    (ii) Medically acceptable alternatives to administration of antipsychotic medications are not available or are unlikely to be successful; and
    (iii) In the opinion of the physician, the consumer's condition constitutes an emergency requiring that treatment be instituted before obtaining an additional concurring opinion by a second physician.
    (b) There is an additional concurring opinion by a second physician for treatment up to thirty days;
    (c) For continued treatment beyond thirty days through the hearing on any one hundred eighty-day petition filed under RCW 71.05.370(7), provided the facility medical director or director's medical designee reviews the decision to medicate a consumer. Thereafter, antipsychotic medication may be administered involuntarily only upon order of the court. The review must occur at least every sixty days.
    (3) The examining physician must sign all one hundred eighty-day petitions for antipsychotic medications files under the authority of RCW 71.05.370(7);
    (4) Consumers committed for one hundred eighty days who refuse or lack the capacity to consent to antipsychotic medications have the right to a court hearing under RCW 71.05.370(7) prior to the involuntary administration of antipsychotic medications;
    (5) In an emergency, antipsychotic medications may be administered prior to the court hearing provided that an examining physician files a petition for an antipsychotic medication order the next judicial day;
    (6) All involuntary medication orders must be consistent with the provisions of RCW 71.05.370 (7)(a) and (b), whether ordered by a physician or the court.
    [Statutory Authority: RCW 71.05.560, 71.34.800, and chapters 71.05 and 71.34 RCW. WSR 04-07-014, § 388-865-0570, filed 3/4/04, effective 4/4/04.]
RCW 71.05.560, 71.34.800, and chapters 71.05 and 71.34 RCW. WSR 04-07-014, § 388-865-0570, filed 3/4/04, effective 4/4/04.